Standard Biotools Inc 8-K, filed Sep 7, 2021
Standard Biotools Inc. (LAB)
About this 8-K
Standard Biotools Inc filed this 8-K on September 7, 2021, reporting on events of August 31, 2021.
Items reported
- Item 2.03: New debt or off-balance-sheet obligation
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of principal executive offices, including zip code) |
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
On August 2, 2021, Fluidigm Corporation, a Delaware corporation (the “Company”), filed a Current Report on Form 8-K (the “Prior 8-K”) indicating that it had entered into a Fourth Amendment (the “Amendment”) to the Loan and Security Agreement dated August 2, 2018, as amended, between the Company and Silicon Valley Bank. The Amendment provided, among other terms described in the Prior 8-K and the Amendment filed therewith, for a new $10.0 million term loan facility, of which the Company had drawn $5.0 million as of the date of the Prior 8-K. On August 31, 2021, the Company drew the remaining $5.0 million available under the term loan, and the term loan facility is now fully drawn. The incremental draw-down proceeds will be available for working capital and general corporate purposes.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| FLUIDIGM CORPORATION | ||||||
| Date: September 7, 2021 | By: | /s/ Nicholas Khadder | ||||
| Nicholas Khadder Senior Vice President, General Counsel, and Secretary | ||||||